William C. Baton

Professional Summary: William C. Baton

William C. Baton is a Partner at Saul Ewing LLP in the firm's Newark and New York offices, where his practice is concentrated on patent litigation within the pharmaceutical and life sciences sectors. His primary focus is on Hatch-Waxman Act (ANDA) litigation, where he represents branded pharmaceutical companies in disputes against generic drug manufacturers. His experience encompasses serving as New Jersey litigation counsel for numerous major pharmaceutical companies in complex, high-stakes patent cases.

While the tracked case data shows one appearance as lead counsel for a defendant, Mr. Baton's practice and his firm's intellectual property group are more frequently engaged on behalf of patent holders/plaintiffs in ANDA litigation. Saul Ewing's patent group has been nationally ranked for the number of cases filed on behalf of patentees and ANDA plaintiffs. The tracked case, Kamdem-ouaffo v. Naturasource International LLC, was a pro se action involving claims of misappropriation that spawned multiple state and federal proceedings and appears to be an outlier from his typical focus on ANDA matters. His broader litigation experience includes disputes over intellectual property assets and trade secrets.

Mr. Baton is a member of Saul Ewing's intellectual property litigation team, which handles matters in federal courts, at the appellate level, and before the Patent Trial and Appeal Board (PTAB), although his personal appearance record in PTAB proceedings is not extensively documented in public sources. The firm's ANDA group has secured notable trial and appellate victories for major pharmaceutical clients, including Takeda and Supernus Pharmaceuticals, in cases where hundreds of millions of dollars in sales were at stake.

Mr. Baton earned his J.D., cum laude, from Seton Hall University School of Law and a B.A., summa cum laude, from Kean University. He is admitted to the bars of New Jersey and New York, as well as multiple federal district courts and the U.S. Court of Appeals for the Federal Circuit.